Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

New Alzheimer’s drug aducanumab: what we know so far – and why more research is still needed

By Eleftheria Kodosaki, Research Associate in Neuroimmunology, Cardiff University
Aurora Veteleanu, PhD Candidate, Neuroscience, Cardiff University
Share this article
The first drug targeting Alzheimer's disease has been approved in 20 years – but its approval isn't based on substantial evidence.

Read complete article

© The Conversation -

Follow us on ...
Facebook Twitter